Jacqueline N. Parker
Affiliations: | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Microbiology Biology, Oncology, Virology Biology, Medicine and SurgeryGoogle:
"Jacqueline Parker"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Roth JC, Cassady KA, Cody JJ, et al. (2014) Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates. Human Gene Therapy. Clinical Development. 25: 16-27 |
Markert JM, Razdan SN, Kuo HC, et al. (2014) A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1048-55 |
Gaston DC, Odom CI, Li L, et al. (2013) Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1. Plos One. 8: e81768 |
Pressey JG, Haas MC, Pressey CS, et al. (2013) CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV. Pediatric Blood & Cancer. 60: 45-52 |
Cody JJ, Scaturro P, Cantor AB, et al. (2012) Preclinical evaluation of oncolytic δγ(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastases. International Journal of Breast Cancer. 2012: 628697 |
Markert JM, Cody JJ, Parker JN, et al. (2012) Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. Journal of Virology. 86: 5304-13 |
Gillory L, Haas M, Friedman G, et al. (2012) Genetically Engineered Herpes Simplex Virus Expressing IL-12 Suppresses Murine Neuroblastoma Tumor Growth Journal of Surgical Research. 172: 196 |
Lin WJ, Zheng X, Lin CC, et al. (2011) Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection. Molecular and Cellular Biology. 31: 3196-207 |
Parker JN, Zheng X, Luckett W, et al. (2011) Strategies for the rapid construction of conditionally-replicating HSV-1 vectors expressing foreign genes as anticancer therapeutic agents. Molecular Pharmaceutics. 8: 44-9 |
Gaston DC, Whitley RJ, Parker JN. (2011) Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery Future Virology. 6: 321-340 |